Biblio

Export 2957 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
J. A. Amorim, Canas, P. M., Tomé, A. R., Rolo, A. P., Agostinho, P., Palmeira, C. M., and Cunha, R. A., “Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-β Peptides Modeling Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 525-536, 2017.
H. An, Choi, B., Park, K. - W., Kim, D. - H., Yang, D. - W., Hong, C. Hyung, Kim, S. Yoon, and Han, S. - H., “The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 55, no. 2, pp. 727-735, 2017.
H. An, Cho, M. - H., Kim, D. - H., Chung, S., and Yoon, S. - Y., “Orexin Impairs the Phagocytosis and Degradation of Amyloid-β Fibrils by Microglial Cells.”, J Alzheimers Dis, vol. 58, no. 1, pp. 253-261, 2017.
S. Anand, Barnes, J. M., Young, S. A., Garcia, D. M., H Tolley, D., Kauwe, J. S. K., and Graves, S. W., “Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer's Disease Using Direct Infusion Mass Spectrometry.”, J Alzheimers Dis, vol. 59, no. 1, pp. 277-290, 2017.
M. Anderson, Xu, F., Ou-Yang, M. - H., Davis, J., Van Nostrand, W. E., and Robinson, J. K., “Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1109-1121, 2017.
C. - H. Andersson, Hansson, O., Minthon, L., Andreasen, N., Blennow, K., Zetterberg, H., Skoog, I., Wallin, A., Nilsson, S., and Kettunen, P., “A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1353-63, 2016.
A. G. Andrade, Bubu, O. M., Varga, A. W., and Osorio, R. S., “The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S255-S270, 2018.
S. André, Ansciaux, E., Saidi, E., Larbanoix, L., Stanicki, D., Nonclercq, D., Elst, L. Vander, Laurent, S., Muller, R. N., and Burtea, C., “Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1547-1565, 2017.
E. Andreadou, Pantazaki, A. A., Daniilidou, M., and Tsolaki, M., “Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 209-222, 2017.
J. Andreotti, Dierks, T., Wahlund, L. - O., and Grieder, M., “Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 981-993, 2017.
S. J. Andrews, Das, D., Anstey, K. J., and Easteal, S., “Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.”, J Alzheimers Dis, vol. 57, no. 2, pp. 423-436, 2017.
D. Andriuta, Roussel, M., Barbay, M., Despretz-Wannepain, S., and Godefroy, O., “Differentiating between Alzheimer's Disease and Vascular Cognitive Impairment: Is the "Memory Versus Executive Function" Contrast Still Relevant?”, J Alzheimers Dis, vol. 63, no. 2, pp. 625-633, 2018.
D. Andriuta, Moullart, V., Schraen, S., Devendeville, A., Meyer, M. - E., and Godefroy, O., “What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?”, J Alzheimers Dis, vol. 51, no. 3, pp. 793-800, 2016.
D. Andriuta, Si-Ahmed, C., Roussel, M., Constans, J. - M., Makki, M., Aarabi, A., Basille, D., Andrejak, C., and Godefroy, O., “Clinical and Imaging Determinants of Neurocognitive Disorders in Post-Acute COVID-19 Patients with Cognitive Complaints.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1239-1250, 2022.
S. Angermann, Schier, J., Baumann, M., Steubl, D., Hauser, C., Lorenz, G., Günthner, R., Braunisch, M. C., Kemmner, S., Satanovskij, R., Haller, B., Heemann, U., Lehnert, T., Bieber, R., Pachmann, M., Braun, J., Scherf, J., Schätzle, G., Fischereder, M., Grimmer, T., and Schmaderer, C., “Cognitive Impairment is Associated with Mortality in Hemodialysis Patients.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1529-1537, 2018.
K. J. Anstey, Eramudugolla, R., Chopra, S., Price, J., and Wood, J. M., “Assessment of Driving Safety in Older Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1197-1205, 2017.
K. J. Anstey, Ashby-Mitchell, K., and Peters, R., “Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis.”, J Alzheimers Dis, vol. 56, no. 1, pp. 215-228, 2017.
A. Antón-Fernández, Merchán-Rubira, J., Avila, J., Hernández, F., DeFelipe, J., and Muñoz, A., “Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model.”, J Alzheimers Dis, vol. 60, no. 2, pp. 651-661, 2017.
I. Apostolova, Lange, C., Roberts, A., Igel, H. Joachim, Mäurer, A., Liese, S., Estrella, M., Prasad, V., Stechl, E., Lämmler, G., Steinhagen-Thiessen, E., and Buchert, R., “Challenges in Screening and Recruitment for a Neuroimaging Study in Cognitively Impaired Geriatric Inpatients.”, J Alzheimers Dis, vol. 56, no. 1, pp. 197-204, 2017.
L. Fortunato Araújo, Mirza, S. Saeed, Bos, D., Niessen, W. J., Barreto, S. Maria, van der Lugt, A., Vernooij, M. W., Hofman, A., Tiemeier, H., and M Ikram, A., “Association of Coffee Consumption with MRI Markers and Cognitive Function: A Population-Based Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 451-61, 2016.
D. Castro Araújo, Veloso, A. Alonso, Gomes, K. Braga, de Souza, L. Cruz, Ziviani, N., and Caramelli, P., “A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 2, pp. 549-561, 2022.
B. A. Ardekani, Bermudez, E., Mubeen, A. M., and Bachman, A. H., “Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 55, no. 1, pp. 269-281, 2017.
B. A. Ardekani, Convit, A., and Bachman, A. H., “Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression.”, J Alzheimers Dis, vol. 50, no. 3, pp. 847-57, 2016.
R. Mc Ardle, Morris, R., Hickey, A., Del Din, S., Koychev, I., Gunn, R. N., Lawson, J., Zamboni, G., Ridha, B., Sahakian, B. J., Rowe, J. B., Thomas, A., Zetterberg, H., MacKay, C., Lovestone, S., and Rochesteron, L., “Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.”, J Alzheimers Dis, vol. 63, no. 1, pp. 331-341, 2018.
R. Mc Ardle, Morris, R., Wilson, J., Galna, B., Thomas, A. J., and Rochester, L., “What Can Quantitative Gait Analysis Tell Us about Dementia and Its Subtypes? A Structured Review.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1295-1312, 2017.

Pages